Nektar Therapeutics 10-K for FY2025
Nektar Therapeutics (NKTR)
10-K
2026-03-13
For: 2025-12-31
View Original
Added on
April 04, 2026
About this 10-K
Nektar Therapeutics filed this 10-K on March 13, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $55.23M
- down 43.9% from $98.43M a year earlier
- Net loss
- $164.08M
- compared with a net loss of $118.96M a year earlier
- Diluted EPS
- -$9.73
- compared with -$8.68 a year earlier